Sugi Predict

Sugi Predict / Compounds / SCHEMBL2608494

SCHEMBL2608494

SCHEMBL2608494

Cc1ccc([N+](=O)[O-])c2nonc12

nearest known ligand 0.61

Predicted protein targets (top 18)

geneUniProtsupporting neighboursconfidence
▸ GSTP1 P09211 3/20 0.61
▸ GSTM2 P28161 3/20 0.61
▸ IDO1 P14902 8/20 0.59
▸ G6PD P11413 1/20 0.57
▸ CASP6 P55212 1/20 0.57
▸ KMT2A Q03164 10/20 0.55
▸ MEN1 O00255 9/20 0.55
▸ USP2 O75604 2/20 0.54
▸ POLB P06746 2/20 0.54
▸ TNNI3 P19429 1/20 0.54
▸ TNNT2 P45379 1/20 0.54
▸ TNNC1 P63316 1/20 0.54
▸ MYC P01106 1/20 0.54
▸ SMN1; SMN2 Q16637 1/20 0.51
▸ GAA P10253 1/20 0.50
▸ L3MBTL1 Q9Y468 1/20 0.50
▸ HTT P42858 1/20 0.50
▸ RECQL P46063 1/20 0.50

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL7052057 0.90 GSTM2 (0.66) GSTP1GSTM2IDO1G6PDCASP6
SCHEMBL5245835 0.82 IDO1 (0.53) GSTP1GSTM2IDO1G6PDCASP6
SCHEMBL5243120 0.82 KMT2A (0.52) GSTP1GSTM2IDO1G6PDCASP6
SCHEMBL5244634 0.81 MEN1 (0.52) GSTP1GSTM2IDO1G6PDCASP6
SCHEMBL10089701 0.80 GSTM2 (0.56) GSTP1GSTM2IDO1G6PDCASP6
SCHEMBL3192786 0.79 IDO1 (0.57) GSTP1GSTM2IDO1G6PDCASP6
SCHEMBL41754 0.79 IDO1 (0.58) GSTP1GSTM2IDO1G6PDCASP6
SCHEMBL18878880 0.79 GSTM2 (0.55) GSTP1GSTM2IDO1G6PDCASP6
SCHEMBL315294 0.79 IDO1 (0.57) GSTP1GSTM2IDO1G6PDCASP6
SCHEMBL3047621 0.79 MEN1 (0.60) GSTP1GSTM2IDO1CASP6KMT2A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 77 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20230270889-A1 Fluorescently-Traceable Amino Acid Derivative And Preparation Methods And Use Thereof Capital Medical University (CN) 2023-08-31 — — US disclosed
US-9773953-B2 Organic phosphor-functionalized nanoparticles and compositions comprising the same RENSSELAER POLYTECHNIC INSTITUTE (US) 2017-09-26 — — US disclosed
WO-2017146400-A1 COMPOUND AND COMPOSITION FOR DETECTING PHOSGENE AND DIETHYL CHLOROPHOSPHATE EWHA UNIVERSITY - INDUSTRY COLLABORATION FOUNDATION (KR) 2017-08-31 — — WO disclosed
US-20170240557-A1 COMPOUND AND COMPOSITION FOR DETECTING PHOSGENE AND DIETHYL CHLOROPHOSPHATE EWHA UNIVERSITY - INDUSTRY COLLABORATION FOUNDATION (KR) 2017-08-24 — — US disclosed
EP-2027453-B1 NONSEPARATION ASSAY METHODS BECKMAN COULTER INC (US) 2017-03-15 — — EP disclosed
EP-2021778-B1 NONSEPARATION ASSAY METHODS BECKMAN COULTER INC (US) 2017-03-15 — — EP disclosed
WO-2017035501-A1 SIALYLTRANSFERASE INHIBITORS AND USES THEREOF ACADEMIA SINICA (TW) 2017-03-02 — — WO disclosed
US-20160049559-A1 ORGANIC PHOSPHOR-FUNCTIONALIZED NANOPARTICLES AND COMPOSITIONS COMPRISING THE SAME RENSSELAER POLYTECHNIC INSTITUTE (US) 2016-02-18 — — US disclosed
US-9242944-B2 Potent analogues of the C-Myc inhibitor 10074-G5 with improved cell permeability UNIVERSITY OF MARYLAND, BALTIMORE (US) 2016-01-26 — — US disclosed
US-9242944-B2 Potent analogues of the C-Myc inhibitor 10074-G5 with improved cell permeability UNIVERSITY OF MARYLAND, BALTIMORE (US) 2016-01-26 — — US disclosed
US-20070264665-A1 Nonseparation assay methods BECKMAN COULTER, INC. 2007-11-15 — — US disclosed
US-20070264664-A1 Nonseparation assay methods NEXGEN DIAGNOSTICS LLC 2007-11-15 — — US disclosed
US-20070264664-A1 Nonseparation assay methods NEXGEN DIAGNOSTICS LLC 2007-11-15 — — US disclosed
US-20070264665-A1 Nonseparation assay methods BECKMAN COULTER, INC. 2007-11-15 — — US disclosed
EP-1845096-A1 12-Aza-epothilones, process for their preparation and their use as antiproliferative agents ETH Zürich (CH) 2007-10-17 — — EP disclosed
US-7282339-B2 Competitive immunoassay INVITROGEN CORPORATION (US) 2007-10-16 — — US disclosed
WO-2007110214-A1 12-AZA-EP0THIL0NES, PROCESS FOR THEIR PREPARATION AND THEIR USE AS ANTIPROLIFERATIVE AGENTS ETH Zürich (CH) 2007-10-04 — — WO disclosed
US-20070172878-A1 Methods using novel chemiluminescent labels LUMIGEN, INC. 2007-07-26 — — US disclosed
US-20070172878-A1 Methods using novel chemiluminescent labels LUMIGEN, INC. 2007-07-26 — — US disclosed
EP-1029016-B1 NOVEL CHEMILUMINESCENT LABELING COMPOUNDS LUMIGEN INC (US) 2007-03-07 — — EP disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (4 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20160049559-A1 ORGANIC PHOSPHOR-FUNCTIONALIZED NANOPARTICLES AND COMPOSITIONS COMPRISING THE SAME CLTA, CLTB, CLTC GSTP1 401/4885GSTM2 1131/4885IDO1 4649/4885
US-20070172878-A1 Methods using novel chemiluminescent labels HLCS, LANCL1, ACR GSTP1 346/4885GSTM2 643/4885IDO1 4210/4885
US-20170240557-A1 COMPOUND AND COMPOSITION FOR DETECTING PHOSGENE AND DIETHYL CHLOROPHOSPHATE DCPS, DCTPP1, PPIP5K2 GSTP1 56/4885GSTM2 1314/4885IDO1 4849/4885
US-20230270889-A1 Fluorescently-Traceable Amino Acid Derivative And Preparation Methods And Use Thereof SLC7A5, BCAT2, BCAT1 GSTP1 3258/4885GSTM2 3310/4885IDO1 2439/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback